AMPH
Price
$26.04
Change
-$0.16 (-0.61%)
Updated
Oct 22 closing price
Capitalization
1.11B
13 days until earnings call
Intraday BUY SELL Signals
BHC
Price
$6.49
Change
+$0.04 (+0.62%)
Updated
Oct 22 closing price
Capitalization
2.43B
5 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AMPH vs BHC

AMPH vs BHC Comparison Chart in %
View a ticker or compare two or three
VS
AMPH vs. BHC commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMPH is a Buy and BHC is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for AMPH with price predictions
Oct 22, 2026

AMPH sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for AMPH moved above the 200-day moving average on October 02, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on AMPH as a result. In 60 of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 75%.

Following a +1.42% 3-day Advance, the price is estimated to grow further. Considering data from situations where AMPH advanced for three days, in 259 of 332 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.

The Aroon Indicator entered an Uptrend today. In 199 of 241 cases where AMPH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 83%.

Bearish Trend Analysis

The 10-day RSI Indicator for AMPH moved out of overbought territory on September 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 44 similar instances where the indicator moved out of overbought territory. In 32 of the 44 cases, the stock moved lower in the following days. This puts the odds of a move lower at 73%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 43 of 67 cases where AMPH's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 64%.

The Moving Average Convergence Divergence Histogram (MACD) for AMPH turned negative on October 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 30 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 65%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMPH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 68%.

AMPH broke above its upper Bollinger Band on September 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. AMPH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 56 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.442) is normal, around the industry mean (10.407). P/E Ratio (14.966) is within average values for comparable stocks, (-6.173). Projected Growth (PEG Ratio) (0.640) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.037) among similar stocks. P/S Ratio (1.522) is also within normal values, averaging (178.797).

The Tickeron SMR rating for this company is 69 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is 88 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMPH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

A.I.Advisor
a Summary for BHC with price predictions
Oct 22, 2026

BHC in upward trend: price rose above 50-day moving average on October 15, 2026

BHC moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend. In 31 of 38 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 29, 2026. You may want to consider a long position or call options on BHC as a result. In 55 of 75 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.

The Moving Average Convergence Divergence (MACD) for BHC just turned positive on October 02, 2026. Looking at past instances where BHC's MACD turned positive, the stock continued to rise in 30 of 42 cases over the following month. The odds of a continued upward trend are 71%.

The 10-day moving average for BHC crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 75%.

Following a +1.09% 3-day Advance, the price is estimated to grow further. Considering data from situations where BHC advanced for three days, in 206 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.

The Aroon Indicator entered an Uptrend today. In 113 of 155 cases where BHC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 73%.

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BHC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.

BHC broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 2 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-1.371) is normal, around the industry mean (10.407). P/E Ratio (-2.207) is within average values for comparable stocks, (-6.173). Projected Growth (PEG Ratio) (0.011) is also within normal values, averaging (2.152). BHC's Dividend Yield (0.616) is considerably higher than the industry average of (0.037). P/S Ratio (0.197) is also within normal values, averaging (178.797).

The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. BHC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BHC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

FUNDAMENTALS RATINGS
AMPH vs BHC: Fundamental Ratings
AMPH
BHC
OUTLOOK RATING
1..100
1538
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
2
Undervalued
PROFIT vs RISK RATING
1..100
88100
SMR RATING
1..100
69100
PRICE GROWTH RATING
1..100
3938
P/E GROWTH RATING
1..100
897
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BHC's Valuation (2) in the Pharmaceuticals Other industry is somewhat better than the same rating for AMPH (56). This means that BHC’s stock grew somewhat faster than AMPH’s over the last 12 months.

AMPH's Profit vs Risk Rating (88) in the Pharmaceuticals Other industry is in the same range as BHC (100). This means that AMPH’s stock grew similarly to BHC’s over the last 12 months.

AMPH's SMR Rating (69) in the Pharmaceuticals Other industry is in the same range as BHC (100). This means that AMPH’s stock grew similarly to BHC’s over the last 12 months.

BHC's Price Growth Rating (38) in the Pharmaceuticals Other industry is in the same range as AMPH (39). This means that BHC’s stock grew similarly to AMPH’s over the last 12 months.

AMPH's P/E Growth Rating (8) in the Pharmaceuticals Other industry is significantly better than the same rating for BHC (97). This means that AMPH’s stock grew significantly faster than BHC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMPHBHC
RSI
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
78%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
64%
Bearish Trend 1 day ago
73%
Momentum
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
73%
MACD
ODDS (%)
Bearish Trend 1 day ago
65%
Bullish Trend 1 day ago
71%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
67%
Bullish Trend 1 day ago
74%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
71%
Advances
ODDS (%)
Bullish Trend 8 days ago
78%
Bullish Trend 1 day ago
75%
Declines
ODDS (%)
Bearish Trend 22 days ago
68%
Bearish Trend 10 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
56%
Bearish Trend 1 day ago
71%
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
73%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (AMPH: $26.04 vs. BHC: $6.49)
Brand notoriety: AMPH: Not notable vs. BHC: Notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AMPH: 67% vs. BHC: 52%
Market capitalization -- AMPH: $1.11B vs. BHC: $2.43B
AMPH [@Pharmaceuticals: Generic] is valued at $1.11B. BHC’s [@Pharmaceuticals: Generic] market capitalization is $2.43B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $68.49B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMPH’s FA Score shows that 1 FA rating(s) are green while BHC’s FA Score has 1 green FA rating(s).

  • AMPH’s FA Score: 1 green, 4 red.
  • BHC’s FA Score: 1 green, 4 red.
According to our system of comparison, AMPH is a better buy in the long-term than BHC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMPH’s TA Score shows that 4 TA indicator(s) are bullish while BHC’s TA Score has 6 bullish TA indicator(s).

  • AMPH’s TA Score: 4 bullish, 5 bearish.
  • BHC’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, BHC is a better buy in the short-term than AMPH.

Price Growth

AMPH (@Pharmaceuticals: Generic) experienced а -1.44% price change this week, while BHC (@Pharmaceuticals: Generic) price change was +2.85% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -3.00%. For the same industry, the average monthly price growth was -9.86%, and the average quarterly price growth was +9.31%.

Reported Earning Dates

AMPH is expected to report earnings on Nov 05, 2026.

BHC is expected to report earnings on Oct 28, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-3.00% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
AMPH
Daily Signal:
Gain/Loss:
BHC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

AMPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMPH has been loosely correlated with AMRX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if AMPH jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMPH
1D Price
Change %
AMPH100%
-0.61%
AMRX - AMPH
45%
Loosely correlated
+1.39%
IXHL - AMPH
40%
Loosely correlated
-5.80%
EBS - AMPH
37%
Loosely correlated
+0.48%
ZTS - AMPH
36%
Loosely correlated
+2.99%
XERS - AMPH
35%
Loosely correlated
+0.70%
More

BHC and

Correlation & Price change

A.I.dvisor tells us that BHC and AMRX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BHC and AMRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHC
1D Price
Change %
BHC100%
+0.62%
AMRX - BHC
32%
Poorly correlated
+1.39%
AMPH - BHC
30%
Poorly correlated
-0.61%
HCM - BHC
28%
Poorly correlated
-0.63%
ZSTK - BHC
25%
Poorly correlated
-5.88%
COLL - BHC
24%
Poorly correlated
+2.55%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BIIB253.8412.86
+5.34%
Biogen
CRVL83.883.17
+3.93%
CorVel Corp
RHLD118.813.57
+3.10%
Resolute Holdings Management
DUOT5.99-0.30
-4.77%
Duos Technologies Group
FABC2.06-0.17
-7.62%
Fabric.AI Inc.